Table 2.

Coverage of PAX8 marker gene detection using deconvoluted RNA-seq data

Patient sample	PAX8+ marker coverage		PAX8- marker coverage
	with scRNA data	without scRNA data	with scRNA data	without scRNA data
EOC0939 pAsc	87%	94%	81%	58%
EOC1103 pOme1	87%	94%	82%	64%
EOC1103 pPer1	87%	91%	82%	70%
EOC1107 pAsc	85%	91%	78%	57%

Coverage was defined as the number of overlapping markers divided by the number of fresh samples markers, where the markers were identified in the fresh tumor samples and after ex vivo culturing using the same marker selection criteria (Wilcoxon test, adjusted P < 0.01 and log fold-change > 1 cutoffs). The total number of PAX8+ and PAX8- markers was 46 and 74, respectively, as detected from the scRNA-seq data of the fresh dissociated tissues.